The Latest Cardiac and Vascular News
Topline data for baxdrostat (CIN-107) in BrigHtn Phase 2 trial for treatment-resistant hypertension (rHTN) expected in 2H 2022 Topline data for baxdrostat (CIN-107) in HALO Phase 2 trial for uncontrolled hypertension (uHTN) expected in 2H 2022 Phase 2 figHTN-CKD trial evaluating baxdrostat’s (CIN-107) utility in ameliorating complications of chronic kidney […]
SILVER SPRING, Md., May 09, 2022 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today provided a business update and reported financial results for the first quarter March 31, […]
Quanterix reports continued revenue growth as it scales to support transformational advances in neurology research BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced financial results for the three months ended March 31, 2022. “This is a […]
ASHLAND, Ore.–(BUSINESS WIRE)–BaroPace, Inc., an innovative biotechnology company focused on treating drug-resistant hypertension and heart failure with preserved ejection fraction (HFpEF), announces the appointment of Michael Coyle to BaroPace’s Board of Directors. As the former Executive Vice President and President for the Cardiovascular Portfolio at Medtronic and Chief Executive Officer […]
SAN FRANCISCO, May 05, 2022 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today reported financial results for the three months ended March 31, 2022. First Quarter 2022 Financial Highlights Revenue of $92.4 million, a 24.3% increase […]
Achieved revenue of $77.2 million in the first quarter 2022 versus $71.1 million in the first quarter of 2021, an increase of 8.6% on a GAAP basis and 11.2% on a non-GAAP constant currency basis ATLANTA, May 5, 2022 /PRNewswire/ — Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced its […]
Conference Call Scheduled for 4:30 PM Eastern Time Today WALTHAM, Mass., May 5, 2022 /PRNewswire/ — Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs, today provided a business update and reported financial results for the first quarter ended March […]
WEST CHESTER, Pa., May 6, 2022 /PRNewswire/ — VESTECK, Inc. is pleased to announce the expansion of their Scientific Advisory Board with the addition of Dr. Dai Yamanouchi. Dr Yamanouchi, a Vascular Surgeon, is an Associate Professor at the University of Wisconsin School of Medicine and Adjunct Professor at Tokyo Medical and Dental University also […]
Signs definitive merger agreement with Cend Therapeutics along with immediate investment and collaboration agreements Maintains strong financial position while advancing and expanding development portfolio Conference call begins today at 4:30 p.m. Eastern time BASKING RIDGE, N.J., May 05, 2022 (GLOBE NEWSWIRE) — Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the […]
Announced positive topline results from Phase 2 SEISMiC study of istaroxime in early cardiogenic shock Late-breaker presentation of additional SEISMiC study results at the European Society of Cardiology (ESC) Heart Failure Conference. Management to host investor call following the presentation on May 23 WARRINGTON, Pa., May 05, 2022 (GLOBE NEWSWIRE) […]
